SOMO·INSIGHT Clinical Study Detects First Cancer in Mammographically Negative Breast Screening Patient at OSF Saint Francis Medical Center

SAN JOSE, Calif. & PEORIA, Ill.--(BUSINESS WIRE)--U-Systems, the leader in dedicated breast ultrasound systems, together with Medical Director Jessica A. Guingrich, MD of OSF Saint Francis Medical Center, Susan G. Komen Breast Center and Centers for Breast Health announced that they have initiated the SOMO·INSIGHT Clinical Study. The first participants have been enrolled and the first pathologically confirmed cancer has been detected in a mammographically-negative screening patient. The clinical study is examining whether Digital Mammography along with the somo•v™ Automated Breast Ultrasound (ABUS) is more sensitive to detecting breast lesions when compared to Mammography alone in women with dense breasts.

The initiation of this nationwide study, which intends to recruit over 20,000 women, is an important milestone for U-Systems in evaluating new approaches to improved cancer detection. Screening mammography can be limited in women with dense breasts and these women have a higher risk of breast cancer. ABUS uses ultrasound (sound waves) at a safe frequency to create images of the internal breast tissue, unlike mammography, which uses radiation. Ultrasound has been shown to find cancer not visible with mammography in women who have dense breasts. A new approach to improving breast cancer detection is critical for women with dense breasts who undergo mammography. It is for this reason that U-Systems developed the somo•v and is sponsoring the SOMO·INSIGHT clinical study.

source: Business Wire